Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I/II Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

Summary

The purpose of this phase I/IIa study is to determine the safety and efficacy of FF-10502-01 in patients with advanced solid tumors and lymphomas. Phase II will consist of 2 cohorts: Cohort 1 will include patients with Pancreatic Cancer. Cohort 2 will include patients with another tumor type enrolled in the Phase I dose-escalation phase who have demonstrated Clinical Benefit by Week 16.

General Information

NCT#: NCT02661542
Study ID: FF-10502-01
Trial Phase: Phase I/II

Trial Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc.
Therapies Used in This Trial: FF-10502-01

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search